Procter & Gamble (NYSE:PG) PT Raised to $190.00 at Citigroup

Procter & Gamble (NYSE:PG) had its target price lifted by equities research analysts at Citigroup from $177.00 to $190.00 in a research note issued on Wednesday, Benzinga reports. The firm presently has a “buy” rating on the stock. Citigroup’s target price suggests a potential upside of 14.79% from the company’s previous close.

A number of other equities research analysts also recently weighed in on PG. Deutsche Bank Aktiengesellschaft lowered their price target on Procter & Gamble from $172.00 to $171.00 and set a “buy” rating for the company in a report on Monday, April 22nd. StockNews.com raised Procter & Gamble from a “hold” rating to a “buy” rating in a research report on Tuesday, June 25th. Jefferies Financial Group upped their price target on Procter & Gamble from $175.00 to $182.00 and gave the company a “buy” rating in a research report on Monday, April 22nd. Argus upped their price target on Procter & Gamble from $180.00 to $185.00 and gave the company a “buy” rating in a research report on Thursday, April 25th. Finally, BNP Paribas began coverage on Procter & Gamble in a research report on Monday, June 24th. They set an “outperform” rating and a $187.00 price target on the stock. Six research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $171.74.

Procter & Gamble Price Performance

PG stock opened at $165.52 on Wednesday. The company has a quick ratio of 0.48, a current ratio of 0.69 and a debt-to-equity ratio of 0.49. Procter & Gamble has a 52-week low of $141.45 and a 52-week high of $169.41. The stock’s 50 day moving average is $166.07 and its two-hundred day moving average is $159.94. The company has a market capitalization of $390.65 billion, a PE ratio of 27.05, a P/E/G ratio of 3.18 and a beta of 0.41.

Procter & Gamble (NYSE:PG) last posted its quarterly earnings data on Friday, April 19th. The company reported $1.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.42 by $0.10. Procter & Gamble had a return on equity of 33.91% and a net margin of 18.00%. The company had revenue of $20.20 billion for the quarter, compared to the consensus estimate of $20.43 billion. During the same period in the previous year, the business earned $1.37 EPS. Procter & Gamble’s revenue for the quarter was up .6% compared to the same quarter last year. Analysts predict that Procter & Gamble will post 6.55 earnings per share for the current fiscal year.

Insider Activity at Procter & Gamble

In related news, CEO R. Alexandra Keith sold 855 shares of the firm’s stock in a transaction dated Monday, April 22nd. The stock was sold at an average price of $158.50, for a total transaction of $135,517.50. Following the completion of the transaction, the chief executive officer now owns 4,004 shares of the company’s stock, valued at $634,634. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In related news, CEO R. Alexandra Keith sold 855 shares of the firm’s stock in a transaction dated Monday, April 22nd. The stock was sold at an average price of $158.50, for a total transaction of $135,517.50. Following the completion of the transaction, the chief executive officer now owns 4,004 shares of the company’s stock, valued at $634,634. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Gary A. Coombe sold 21,388 shares of the company’s stock in a transaction on Tuesday, May 7th. The shares were sold at an average price of $164.98, for a total value of $3,528,592.24. Following the sale, the chief executive officer now directly owns 36,854 shares of the company’s stock, valued at $6,080,172.92. The disclosure for this sale can be found here. Insiders sold 154,544 shares of company stock valued at $25,413,051 over the last 90 days. 0.17% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Procter & Gamble

Several hedge funds have recently modified their holdings of PG. Alera Investment Advisors LLC lifted its holdings in shares of Procter & Gamble by 1.2% in the first quarter. Alera Investment Advisors LLC now owns 5,007 shares of the company’s stock valued at $812,000 after purchasing an additional 60 shares in the last quarter. Fiduciary Alliance LLC lifted its holdings in shares of Procter & Gamble by 2.8% in the second quarter. Fiduciary Alliance LLC now owns 2,261 shares of the company’s stock valued at $371,000 after purchasing an additional 61 shares in the last quarter. Demars Financial Group LLC lifted its holdings in shares of Procter & Gamble by 4.4% in the fourth quarter. Demars Financial Group LLC now owns 1,497 shares of the company’s stock valued at $219,000 after purchasing an additional 63 shares in the last quarter. LCM Capital Management Inc lifted its holdings in shares of Procter & Gamble by 1.1% in the first quarter. LCM Capital Management Inc now owns 5,701 shares of the company’s stock valued at $925,000 after purchasing an additional 63 shares in the last quarter. Finally, Prentice Wealth Management LLC lifted its holdings in shares of Procter & Gamble by 1.6% in the second quarter. Prentice Wealth Management LLC now owns 4,059 shares of the company’s stock valued at $669,000 after purchasing an additional 64 shares in the last quarter. 65.77% of the stock is owned by hedge funds and other institutional investors.

About Procter & Gamble

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.